Antiretroviral therapy: reverse transcriptase inhibition.
作者信息
Connolly K J, Hammer S M
机构信息
Department of Medicine, New England Deaconess Hospital, Boston, Massachusetts.
出版信息
Antimicrob Agents Chemother. 1992 Feb;36(2):245-54. doi: 10.1128/AAC.36.2.245.
Abstract
摘要
相似文献
1
Antiretroviral therapy: reverse transcriptase inhibition.抗逆转录病毒疗法：逆转录酶抑制作用
Antimicrob Agents Chemother. 1992 Feb;36(2):245-54. doi: 10.1128/AAC.36.2.245.
2
Antiretroviral drug resistance: mechanisms, pathogenesis, clinical significance.
Adv Exp Med Biol. 1996;394:383-95. doi: 10.1007/978-1-4757-9209-6_35.
3
Efficacy of combination antiretroviral therapy.
Adv Exp Med Biol. 1996;394:355-72. doi: 10.1007/978-1-4757-9209-6_33.
4
5
Immunologic issues in anti-retroviral therapy.抗逆转录病毒疗法中的免疫学问题。
Immunol Today. 1990 Sep;11(9):327-33. doi: 10.1016/0167-5699(90)90128-v.
6
Antiviral efficacy of Imexon in the Rauscher murine retrovirus AIDS model.
Immunopharmacol Immunotoxicol. 1990;12(1):1-21. doi: 10.3109/08923979009006458.
7
Quick reference guide to antiretrovirals.
Eur J Med Res. 2001 May 29;6(5):219-27.
8
Antiretroviral drug development and clinical pharmacology.抗逆转录病毒药物研发与临床药理学
Pediatr Infect Dis J. 1991 Nov;10(11):849-57. doi: 10.1097/00006454-199111000-00012.
9
[The role of stavudine in antiretroviral therapy].司他夫定在抗逆转录病毒治疗中的作用
Presse Med. 1998 Oct 31;27(33):1708-9.
10
New initiatives in combination antiretroviral chemotherapy.联合抗逆转录病毒化疗的新举措。
Adv Exp Med Biol. 1996;394:373-82. doi: 10.1007/978-1-4757-9209-6_34.
引用本文的文献
1
Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptase.针对人类免疫缺陷病毒1型（HIV-1）感染的化学屏障：UC781的杀逆转录病毒活性，一种HIV-1逆转录酶的硫代羧酰苯胺类非核苷抑制剂
J Virol. 1997 Apr;71(4):3023-30. doi: 10.1128/JVI.71.4.3023-3030.1997.
2
Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription.人类免疫缺陷病毒逆转录过程中核苷类似物抗病毒活性及耐药性的机制
Antimicrob Agents Chemother. 1996 Mar;40(3):527-40. doi: 10.1128/AAC.40.3.527.
3
Comparative pharmacokinetics, distributions in tissue, and interactions with blood proteins of conventional and sterically stabilized liposomes containing 2',3'-dideoxyinosine.含2',3'-双脱氧肌苷的常规脂质体和空间稳定脂质体的比较药代动力学、组织分布及与血液蛋白的相互作用
Antimicrob Agents Chemother. 1996 Jan;40(1):225-9. doi: 10.1128/AAC.40.1.225.
4
Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.1型人类免疫缺陷病毒的病毒背景在对蛋白酶抑制剂耐药性的产生中起主要作用。
Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1648-53. doi: 10.1073/pnas.93.4.1648.
5
Effect of 3'-azido-3'-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages.3'-叠氮-3'-脱氧胸苷对人胎儿脑巨噬细胞中1型人类免疫缺陷病毒复制的影响。
Antimicrob Agents Chemother. 1993 Jun;37(6):1305-12. doi: 10.1128/AAC.37.6.1305.
6
Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).人类免疫缺陷病毒感染中的抗病毒治疗。现状（第二部分）
Drugs. 1993 May;45(5):637-53. doi: 10.2165/00003495-199345050-00002.
7
Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.抗逆转录病毒疗法：超越单药逆转录酶抑制的策略。
Antimicrob Agents Chemother. 1992 Mar;36(3):509-20. doi: 10.1128/AAC.36.3.509.
本文引用的文献
1
Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1.双脱氧核苷在体外对2型人类免疫缺陷病毒（HIV - 2）的抑制作用比对HIV - 1的抑制作用小。
Antimicrob Agents Chemother. 1987 Dec;31(12):1879-81. doi: 10.1128/AAC.31.12.1879.
2
Nail pigmentation changes associated with azidothymidine (zidovudine).与叠氮胸苷（齐多夫定）相关的指甲色素沉着变化。
Ann Intern Med. 1987 Sep;107(3):350. doi: 10.7326/0003-4819-107-2-350.
3
4
Treatment of human immunodeficiency virus infections.人类免疫缺陷病毒感染的治疗。
Antimicrob Agents Chemother. 1987 Jun;31(6):839-43. doi: 10.1128/AAC.31.6.839.
5
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.齐多夫定（AZT）治疗艾滋病及艾滋病相关综合征患者的毒性。一项双盲、安慰剂对照试验。
N Engl J Med. 1987 Jul 23;317(4):192-7. doi: 10.1056/NEJM198707233170402.
6
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.叠氮胸苷（AZT）治疗艾滋病及艾滋病相关综合征患者的疗效。一项双盲、安慰剂对照试验。
N Engl J Med. 1987 Jul 23;317(4):185-91. doi: 10.1056/NEJM198707233170401.
7
8
Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection.齐多夫定（AZT）持续静脉输注对有症状HIV感染儿童的影响。
N Engl J Med. 1988 Oct 6;319(14):889-96. doi: 10.1056/NEJM198810063191401.
9
Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex.齐多夫定（AZT）治疗艾滋病及艾滋病相关综合征患者的神经心理学转归
N Engl J Med. 1988 Dec 15;319(24):1573-8. doi: 10.1056/NEJM198812153192404.
10
Zotero 插件